E Jezerskyte1, L M Saadeh2, E R C Hagens1, M A G Sprangers3, L Noteboom1, H W M van Laarhoven4, W J Eshuis1, M I van Berge Henegouwen1, S S Gisbertz5. 1. Department of Surgery, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands. 2. General Surgery Unit, University Hospital of Padua, Padua, Italy. 3. Department of Medical Psychology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands. 4. Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands. 5. Department of Surgery, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands. s.s.gisbertz@amsterdamumc.nl.
Abstract
BACKGROUND: There is scarce evidence on whether a total gastrectomy or an Ivor Lewis esophagectomy is preferred for gastroesophageal junction (GEJ) cancers regarding effects on morbidity, pathology, survival and health-related quality of life (HR-QoL). The aim of this study was to investigate the difference in long-term HR-QoL in patients undergoing total gastrectomy versus Ivor Lewis esophagectomy in a tertiary referral center. METHODS: Patients with a follow-up of >1 year after a total gastrectomy or an Ivor Lewis esophagectomy for GEJ/cardia carcinoma completed the EORTC QLQ-C30 and EORTC QLQ-OG25 questionnaires. 'Problems with eating,' 'reflux,' and 'nausea and vomiting' were the primary HR-QoL endpoints. The secondary endpoints were the remaining HR-QoL domains, postoperative complications and pathology results. RESULTS: Thirty patients after gastrectomy and 71 after esophagectomy were included. Mean age was 63 years. Median follow-up was 2 years (range 12-84 months). Patients after gastrectomy reported less 'choking when swallowing' and 'coughing' (β = - 5.952, 95% CI - 9.437 to - 2.466; β = - 13.084, 95% CI - 18.525 to - 7.643). More lymph nodes were resected in esophagectomy group (p = 0.008). No difference was found in number of positive lymph nodes, R0 resection or postoperative complications. CONCLUSIONS: After a follow-up of >1 year 'choking when swallowing' and 'coughing' were less common after a total gastrectomy. No differences were found in postoperative complications or radicality of surgery. Based on this study, no general preference can be given to either of the procedures for GEJ cancer. These results support shared decision making when a choice between the two treatment options is possible.
BACKGROUND: There is scarce evidence on whether a total gastrectomy or an Ivor Lewis esophagectomy is preferred for gastroesophageal junction (GEJ) cancers regarding effects on morbidity, pathology, survival and health-related quality of life (HR-QoL). The aim of this study was to investigate the difference in long-term HR-QoL in patients undergoing total gastrectomy versus Ivor Lewis esophagectomy in a tertiary referral center. METHODS:Patients with a follow-up of >1 year after a total gastrectomy or an Ivor Lewis esophagectomy for GEJ/cardia carcinoma completed the EORTC QLQ-C30 and EORTC QLQ-OG25 questionnaires. 'Problems with eating,' 'reflux,' and 'nausea and vomiting' were the primary HR-QoL endpoints. The secondary endpoints were the remaining HR-QoL domains, postoperative complications and pathology results. RESULTS: Thirty patients after gastrectomy and 71 after esophagectomy were included. Mean age was 63 years. Median follow-up was 2 years (range 12-84 months). Patients after gastrectomy reported less 'choking when swallowing' and 'coughing' (β = - 5.952, 95% CI - 9.437 to - 2.466; β = - 13.084, 95% CI - 18.525 to - 7.643). More lymph nodes were resected in esophagectomy group (p = 0.008). No difference was found in number of positive lymph nodes, R0 resection or postoperative complications. CONCLUSIONS: After a follow-up of >1 year 'choking when swallowing' and 'coughing' were less common after a total gastrectomy. No differences were found in postoperative complications or radicality of surgery. Based on this study, no general preference can be given to either of the procedures for GEJ cancer. These results support shared decision making when a choice between the two treatment options is possible.
Authors: Kush R Lohani; Kalyana C Nandipati; Sarah E Rollins; Katharina Fetten; Tommy H Lee; Pradeep K Pallati; Se Ryung Yamamoto; Sumeet K Mittal Journal: Surg Endosc Date: 2014-11-01 Impact factor: 4.584
Authors: Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke Journal: J Clin Epidemiol Date: 2008-04 Impact factor: 6.437
Authors: Annemieke Cats; Edwin P M Jansen; Nicole C T van Grieken; Karolina Sikorska; Pehr Lind; Marianne Nordsmark; Elma Meershoek-Klein Kranenbarg; Henk Boot; Anouk K Trip; H A Maurits Swellengrebel; Hanneke W M van Laarhoven; Hein Putter; Johanna W van Sandick; Mark I van Berge Henegouwen; Henk H Hartgrink; Harm van Tinteren; Cornelis J H van de Velde; Marcel Verheij Journal: Lancet Oncol Date: 2018-04-09 Impact factor: 41.316
Authors: R R J Coebergh van den Braak; L B van Rijssen; J J van Kleef; G R Vink; M Berbee; M I van Berge Henegouwen; H J Bloemendal; M J Bruno; M C Burgmans; O R C Busch; P P L O Coene; V M H Coupé; J W T Dekker; C H J van Eijck; M A G Elferink; F L G Erdkamp; W M U van Grevenstein; J W B de Groot; N C T van Grieken; I H J T de Hingh; M C C M Hulshof; J N M Ijzermans; L Kwakkenbos; V E P P Lemmens; M Los; G A Meijer; I Q Molenaar; G A P Nieuwenhuijzen; M E de Noo; L V van de Poll-Franse; C J A Punt; R C Rietbroek; W W H Roeloffzen; T Rozema; J P Ruurda; J W van Sandick; A H W Schiphorst; H Schipper; P D Siersema; M Slingerland; D W Sommeijer; M C W Spaander; M A G Sprangers; H B A C Stockmann; M Strijker; G van Tienhoven; L M Timmermans; M L R Tjin-A-Ton; A M T van der Velden; M J Verhaar; H M Verkooijen; W J Vles; J M P G M de Vos-Geelen; J W Wilmink; D D E Zimmerman; M G H van Oijen; M Koopman; M G H Besselink; H W M van Laarhoven Journal: Acta Oncol Date: 2017-07-19 Impact factor: 4.089
Authors: N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes Journal: J Natl Cancer Inst Date: 1993-03-03 Impact factor: 13.506
Authors: Sebastian Brinkmann; Wolfgang Schroeder; Kristina Junggeburth; Christian A Gutschow; Marc Bludau; Arnulf H Hoelscher; Jessica M Leers Journal: J Thorac Cardiovasc Surg Date: 2016-01-22 Impact factor: 5.209
Authors: Laura Fransen; Gijs Berkelmans; Emanuele Asti; Mark Van Berge Henegouwen; Felix Berlth; Luigi Bonavina; Andrew Brown; Christiane Bruns; Suzanne Gisbertz; Peter Grimminger; Christian Gutschow; Arnulf Hölscher; Juha Kauppi; Sjoerd M Lagarde; Stuart Mercer; Johnny Moons; Philippe Nafteux; Magnus Nilsson; Francesco Palazzo; Piet Pattyn; Annouck Philippron; Dimitri Raptis; Jari Räsänen; Ernest Rosato; Ioannis Rouvelas; Henner Schmidt; Paul Schneider; Wolfgang Schröder; Bas P L Wijnhoven; A P Grard; Misha Luyer Journal: Dis Esophagus Date: 2018-09-01 Impact factor: 3.429